Number of participating innovations and countries per year 2007-2023

Country

Prize

Organization

Innovation

Description

Country

Estonia

Prize

Enteprises

Organization

Molcode Ltd

Innovation

REACH QSAR

Description

Establish a decision system through big data analysis to enable the visual display of real time quality data of all production processes, intelligent detection and prediction of any quality abnormity, and automatically manage quality activities in digital way.

Country

Estonia

Prize

Innovation of Innovations

Organization

Estonian Academy of Security Sciences

Innovation

Enhanced innovative interactive training service supported by a virtual environment

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Estonia

Prize

Public sector and nonprofit organizations

Organization

Estonian Academy of Security Sciences

Innovation

Enhanced innovative interactive training service supported by a virtual environment

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Honorable mention

Organization

MEK – Matkailun edistämiskeskus

Innovation

Revontulet viraalikampanja

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Honorable mention

Organization

Savonlinnan Oopperajuhlat

Innovation

Free Will

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Large companies

Organization

Metsä Fibre Oy

Innovation

Botnia FOX

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Microenterprises

Organization

Codespace

Innovation

DiveMax

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Potential innovations

Organization

MotoCut Oy

Innovation

Katkaisukoura

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Public sector and nonprofit organizations

Organization

The City of Espoo

Innovation

Lonkkaliukumäki

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Responsible innovations

Organization

Ruukki Metals Oy

Innovation

Cr6+

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Small and medium sized enterprises

Organization

QPR Software Oyj

Innovation

QPR ProcessAnalyzer

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Latvia

Prize

Enteprises

Organization

GRANDEG SIA

Innovation

Pellet- and biomass-fired heating boiler

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Latvia

Prize

Public sector and nonprofit organizations

Organization

State Agency of Medicines of Latvia

Innovation

The Map of Latvian Pharmacies

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Sweden

Prize

Large companies

Organization

Volvo Construction Equipment

Innovation

New business model

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Sweden

Prize

Potential innovations

Organization

Appva AB

Innovation

Medication and care support system

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Sweden

Prize

Public sector and nonprofit organizations

Organization

Municipality of Upplands Väsby

Innovation

Väsby Labs

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Sweden

Prize

Small and medium sized enterprises

Organization

Natur&Kultur

Innovation

The Isle of Qnodds

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.